HMOX1 and glioblastoma: Our results establish the central role of HO‐1 in macrophage‐mediated immune suppression present in the glioblastoma microenvironment, and suggest the possibility of reprogramming these cells in the TME by exploiting the iron metabolic pathway in order to restore antitumor cytotoxic immunity and, eventually, boost immunotherapy.